Dissolution pending
Corporations Canada has marked this corporation for dissolution because its annual returns have not been filed. To avoid dissolution, the overdue returns need to be filed.
ENDOCEUTICS, INC. is a federal corporation with dissolution pending (corporation number 4372069). Its business number is 850923327. It was incorporated on Jun 20, 2006 under the Canada Business Corporations Act and its registered office is in Québec, Quebec. Annual returns for 2025 and 2026 are overdue. It has one director on record.
Restructuring under the CCAA
The Office of the Superintendent of Bankruptcy lists a court-supervised restructuring under the Companies' Creditors Arrangement Act for “ENDOCEUTICS INC.”, with a first court order on Sep 26, 2022.
Court-supervised restructuring
- Court
- Cour Supérieure (Chambre Commerciale) District de Québec
- Court file number
- 200-11-028152-224
- First order
- Sep 26, 2022
- Discharge order
- None listed
- Court-appointed monitor
- ERNST & YOUNG INC.
The records list names the company “ENDOCEUTICS INC.”; it is shown here because no other corporation on this site has that exact name. The monitor's page has the court documents.
Corporate details
- Corporation number
- 4372069
- Business number
- 850923327
- Status
- Dissolution pending Annual filings overdue
- Governing law
- Canada Business Corporations Act
- Incorporated
- Jun 20, 2006
- Corporation type
- Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2023 annual return.
- Registered office
- 100-1195 rue Louis-Adolphe-Robitaille
Québec QC G1S 0B8 - Number of directors
- At least 1, at most 12As the articles allow.
Annual filings
- Anniversary date
- Jun 20The date of incorporation, amalgamation or continuance.
- Annual filing period
- Jun 20 to Aug 19 each year
- Last annual meeting
- May 26, 2023
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Overdue | |
| 2025 | Overdue | |
| 2024 | Filed |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
2 agreements since 2018, worth $466,200 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | Development of a new oral formulation of DHEA | $416,200 | Aug 5, 2019 |
| National Research Council Canada | ARP - Feasibility - Development of analytics methods | $50,000 | Nov 23, 2018 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| ENDOCEUTICS, INC. | Name | Jun 20, 2006 |
Filings and certificates
| What | Date |
|---|---|
| Articles amended | Nov 1, 2007 |
| Incorporated | Jun 20, 2006 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.